Langer Lab company gets $5M in funding for drug-delivery device

Langer Lab startup SQZ Biotech raised $5 million in a Series A round led by Polaris Venture Partners to support its method to gain entry into a cell's membrane by first squeezing it through a device. SQZ touts it as a replacement for viral vectors. More from FierceBiotech

Suggested Articles

Swiss scientists are using ultrasound to trap and deliver drugs in the brain, a non-invasive delivery method that could help target tumors, too.

Alexion's 100 mg/ml Ultomiris formulation is expected to slash infusion times by about 60% and bodes well for a planned subcutaneous version, too.

Kindeva, which produces inhalers, transdermal patches and other medical devices, is expanding operations in the St. Paul, Minnesota, area.